Health Canada flags possible capsule mix-up in two Taro candesartan batches
A national, retail-level recall of Taro-Candesartan 8 mg tablets lists Sun Pharma Canada as the firm, with esomeprazole capsules possibly present in the affected packs.
16 Nov 2026 · Health Canada · Regulator
Health Canada has issued a Type II recall for two batches of Taro-Candesartan 8 mg tablets, warning that 20 mg esomeprazole capsules could be present in the product. The notice, updated on 16 November 2026, classes the problem as a product quality issue. It is filed under reference RA-82965.
Subscribe to keep reading
$4.99 / month
- Every article, analysis and opinion piece on CompePharma and VigiEye
- One subscription for both sites, cancel any time
or
Official record: Health Canada ↗
Written by CompePharma's editorial system from the official record. AI-assisted; check the source before acting. Not investment advice.
More Manufacturing & supplyAll →
Manufacturing & supply
Health Canada lists Class II recall of Stryker's Blueprint shoulder-planning software over two bugs
18 Nov 2026 · Health Canada · Regulator
Manufacturing & supply
Teleflex recalls PICC kits and spring-wire guides over coating detachment risk, Health Canada reports
18 Nov 2026 · Health Canada · Regulator
Manufacturing & supply
Health Canada: Raz Design recalls shower commode chairs over seats that can break
18 Nov 2026 · Health Canada · Regulator
Manufacturing & supply
Lantern Pharma opens first TNBC trial site, starts HARMONIC Part 2 in Taiwan; CEO resigns
18 Nov 2026 · Lantern Pharma Inc. LTRN · Company news
Manufacturing & supply
OXB confirms manufacturing deal with Aura Biosciences for bel-sar Phase 3 and commercial supply
17 Nov 2026 · OXB · Company news
Manufacturing & supply
Diagnostica Stago recalls lot of STHEMO DDi M, Dutch inspectorate notice shows
17 Nov 2026 · IGJ · Regulator